Schechter M - Search Results

1

HIV-1 DNA predicts disease progression and post-treatment virological control.

Williams JP, Hurst J, Stöhr W, Robinson N, Brown H, Fisher M, Kinloch S, Cooper D, Schechter M, Tambussi G, Fidler S, Carrington M, Babiker A, Weber J, Koelsch KK, Kelleher AD, Phillips RE, Frater J; SPARTACTrial Investigators. Williams JP, et al. Among authors: schechter m. Elife. 2014 Sep 12;3:e03821. doi: 10.7554/eLife.03821. Elife. 2014. PMID: 25217531 Free PMC article.

2

Temporal changes in causes of death among HIV-infected patients in the HAART era in Rio de Janeiro, Brazil.

Pacheco AG, Tuboi SH, May SB, Moreira LF, Ramadas L, Nunes EP, Merçon M, Faulhaber JC, Harrison LH, Schechter M. Pacheco AG, et al. Among authors: schechter m. J Acquir Immune Defic Syndr. 2009 Aug 15;51(5):624-30. doi: 10.1097/QAI.0b013e3181a4ecf5. J Acquir Immune Defic Syndr. 2009. PMID: 19430304 Free PMC article.

3

Monotherapy with Lopinavir/Ritonavir as maintenance after HIV-1 viral suppression: results of a 96-week randomized, controlled, open-label, pilot trial (KalMo study).

Nunes EP, Santini de Oliveira M, Merçon M, Zajdenverg R, Faulhaber JC, Pilotto JH, Ribeiro JE, Norton M, Schechter M. Nunes EP, et al. Among authors: schechter m. HIV Clin Trials. 2009 Nov-Dec;10(6):368-74. doi: 10.1310/hct1006-368. HIV Clin Trials. 2009. PMID: 20133267 Clinical Trial.

4

Risk-based assessment does not distinguish between recent and chronic HIV-1 infection in Rio de Janeiro, Brazil.

Merçon M, Tuboi SH, Batista SM, Telles SR, Grangeiro JR, Zajdenverg R, Lago RF, Barroso PF, Melo Mde F, Schechter M. Merçon M, et al. Among authors: schechter m. Braz J Infect Dis. 2009 Aug;13(4):272-5. doi: 10.1590/s1413-86702009000400006. Braz J Infect Dis. 2009. PMID: 20231989

5

Short-course antiretroviral therapy in primary HIV infection.

SPARTAC Trial Investigators; Fidler S, Porter K, Ewings F, Frater J, Ramjee G, Cooper D, Rees H, Fisher M, Schechter M, Kaleebu P, Tambussi G, Kinloch S, Miro JM, Kelleher A, McClure M, Kaye S, Gabriel M, Phillips R, Weber J, Babiker A. SPARTAC Trial Investigators, et al. Among authors: schechter m. N Engl J Med. 2013 Jan 17;368(3):207-17. doi: 10.1056/NEJMoa1110039. N Engl J Med. 2013. PMID: 23323897 Free PMC article. Clinical Trial.

6

Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population.

Rodger AJ, Lodwick R, Schechter M, Deeks S, Amin J, Gilson R, Paredes R, Bakowska E, Engsig FN, Phillips A; INSIGHT SMART, ESPRIT Study Groups. Rodger AJ, et al. Among authors: schechter m. AIDS. 2013 Mar 27;27(6):973-979. doi: 10.1097/QAD.0b013e32835cae9c. AIDS. 2013. PMID: 23698063 Clinical Trial.

7

Rating evidence in treatment guidelines: a case example of when to initiate combination antiretroviral therapy (cART) in HIV-positive asymptomatic persons.

Sabin CA, Cooper DA, Collins S, Schechter M. Sabin CA, et al. Among authors: schechter m. AIDS. 2013 Jul 31;27(12):1839-46. doi: 10.1097/qad.0b013e328360d546. AIDS. 2013. PMID: 24179998 Review.

8

Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapy.

Stöhr W, Fidler S, McClure M, Weber J, Cooper D, Ramjee G, Kaleebu P, Tambussi G, Schechter M, Babiker A, Phillips RE, Porter K, Frater J. Stöhr W, et al. Among authors: schechter m. PLoS One. 2013 Oct 25;8(10):e78287. doi: 10.1371/journal.pone.0078287. eCollection 2013. PLoS One. 2013. PMID: 24205183 Free PMC article. Clinical Trial.

9

Interleukin-6 and D-dimer levels at seroconversion as predictors of HIV-1 disease progression.

Hamlyn E, Fidler S, Stöhr W, Cooper DA, Tambussi G, Schechter M, Miro JM, Mcclure M, Weber J, Babiker A, Porter K; SPARTAC Trial Investigators. Hamlyn E, et al. Among authors: schechter m. AIDS. 2014 Mar 27;28(6):869-74. doi: 10.1097/QAD.0000000000000155. AIDS. 2014. PMID: 24300544 Clinical Trial.

10

Enhanced normalisation of CD4/CD8 ratio with early antiretroviral therapy in primary HIV infection.

Thornhill J, Inshaw J, Oomeer S, Kaleebu P, Cooper D, Ramjee G, Schechter M, Tambussi G, Fox J, Miro JM, Weber J, Babiker A, Porter K, Fidler S. Thornhill J, et al. Among authors: schechter m. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19480. doi: 10.7448/IAS.17.4.19480. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25393989 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,298 results

Search Page